豪森藥業
      • Overview
      • 1995 Initial establishment
        A principal subsidiary of Hansoh Pharma (03692.HK)
        7
        Launched innovative drugs
        Top 100
        Pharmaceutical companies worldwide
        Top 3
        China's best Industrial enterprises in pharmaceutical R&D pipeline

      Therapy Areas

      • Anti-tumor
        Anti-tumor
        Anti-tumor
        Anti-tumor
        Anti-tumor
        Anti-tumor
        We focus on the develoment of new drugs in the field of common and hostile cancers.Our innovative medicine programs in clinical trials include HS-20106 injection, HS-20105 injection, HS-20117 injection, HS-10516 capsules, HS-10382 tablets, HS-10370 tablets, HS-10502 tablets, HS-10365 capsules, HS-20089 injection, HS-20093 injection, HS-10352 tablets, HS-10241 tablets, etc.
        More +
      • Anti-infectives
        Anti-infectives
        Anti-infectives
        Anti-infectives
        Anti-infectives
        Anti-infectives
        We focus on the development of new drugs in the fields of antiviral, anti-complex bacterial infection and anti-fungal infection. Our innovative medicine programs in clinical trials includeCitric Acid Erythorbate tablets, etc.
        More +
      • CNS Diseases
        CNS Diseases
        CNS Diseases
        CNS Diseases
        CNS Diseases
        CNS Diseases
        We focus on the development of new drugs in the fields of psychiatric and neurological disorders.Our innovative medicine programs in clinical trials include HS-10380 tablets, HS-10506 tablets, HS-10353 capsules, HS-10509 tablets, etc.
        More +
      • Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        We focus on the development of new drugs in the field of metabolic diseases such as diabetes and obesity. Our innovative medicine programs in clinical trials include HS-10511 tablets, HS-20094 injection, HS-10384 tablets, HS-10518 capsules, HS-10390 tablets, HS-10501 tablets, and HS-10398 capsules, etc.
        More +
      • Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        We focus on the development of new drugs in the field of autoimmune diseases. Our innovative medicine programs in clinical trials includeHS-10374 tablets etc.
        More +
      R&D
      Innovation
      Jiangsu Hansoh Pharma Research Institute
      Jiangsu Hansoh Pharma Research Institute
      More
      Jiangsu Hansoh Pharma Administrative R&D Center
      Jiangsu Hansoh Pharma Administrative R&D Center
      More
      • Substantial investment on R&D
        In the first half of 2025, R&D expenditure was approximately RMB1,441 million, and accounted for approximately 19.4% of the revenue.
      • Competitive R&D pipeline
        More than 70 clinical trials of innovative drugs being investigated, covering more than 40 innovative drug candidates.
      • Highly efficient capability to discover innovative drugs
        The R&D pipeline covers peptides , small molecules, biologics, ADC drugs, siRNAs, and more.
      A broader world, let's discover together
      Join Hansoh Pharma +
      Work with us
      We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
      Join Hansoh Pharma +
      亚洲国产精品日韩专区AV| 国产精品亚洲一区二区麻豆| 久久精品国产亚洲av麻豆 | 日本红怡院亚洲红怡院最新 | 国产亚洲精品精品精品| 亚洲高清一区二区三区电影| 亚洲AV综合色区无码二区爱AV| 亚洲精品成人图区| 久久精品国产亚洲AV电影| 亚洲乱亚洲乱淫久久| 亚洲欧洲日韩不卡| 亚洲Av无码精品色午夜| 亚洲大片在线观看| 亚洲国产精品第一区二区 | 含羞草国产亚洲精品岁国产精品| 亚洲色大成WWW亚洲女子| 亚洲一区二区无码偷拍| 亚洲一卡2卡三卡4卡无卡下载| 中文字幕 亚洲 有码 在线 | 亚洲熟妇av一区二区三区漫画| 国产亚洲大尺度无码无码专线| 在线观看亚洲成人| 国产成A人亚洲精V品无码| 亚洲AV无码一区二区二三区软件| 亚洲AV综合色区无码一区| 亚洲av无码国产精品夜色午夜| 亚洲国产精品热久久| 久久久无码精品亚洲日韩蜜臀浪潮| 色拍自拍亚洲综合图区| 亚洲狠狠ady亚洲精品大秀| 亚洲av成人综合网| 亚洲欧好州第一的日产suv| 激情小说亚洲图片| 精品国产香蕉伊思人在线在线亚洲一区二区 | 好看的电影网站亚洲一区| 久久精品夜色国产亚洲av| 91亚洲精品第一综合不卡播放| 亚洲无线一二三四区| 亚洲kkk4444在线观看| 性色av极品无码专区亚洲 | 亚洲精品中文字幕麻豆|